Summary. Platelet aggregation in response to collagen, adenosine diphosphate and arachidonic acid was studied prospectively in 30 children with Type 1 (insulin-dependent) diabetes mellitus. The studies began on admission to hospital and continued throughout the two years following diagnosis. The results were compared with those in 44 healthy control children. Collagen-induced aggregation was significantly decreased in the diabetic children on admission in comparison to the healthy children. In contrast, the aggregation induced by adenosine diphosphate (1.1 p~mol/1, p < 0.05) and arachidonic acid (0.25 mmol/1, p < 0.05) was increased on admission. The magnitude of the platelet shape change after adenosine diphosphate stimulation was small at the onset of the disease but was significantly increased towards normal during the two years of follow-up. On admission, the primary wave aggregation induced by adenosine diphosphate was positively and significantly correlated to some of the lipoprotein fractions that were disturbed at that time, especially triglycerides in high-density lipoproteins. After two years of treatment the platelet aggregability in the diabetic children had been restored to normal.
An abnormal interaction between the platelet and blood vessel wall contributing to microangiopathy in Type 1 (insulin-dependent) diabetes mellitus has been recently suggested [1] [2] [3] [4] . In cross-sectional studies on adult subjects with Type 1 diabetes and investigations on experimental diabetes in animals, several authors have convincingly demonstrated functional abnormalities of platelets in vitro [1, [4] [5] [6] [7] [8] [9] and in vivo as measured by platelet survival and plasma beta-thromboglobulin levels [2, 7, 10, 11] . The typical functional aberration in vitro is an increased sensitivity to aggregating agents such as collagen, adenosine diphosphate (ADP) and arachidonic acid (AA), whereby the so called irreversible phase or the release reaction is enhanced, which can be explained by the finding of an increased production of proaggregatory eicosanoid metabolites in platelets from patients with Type 1 diabetes [12] .
There is also convincing evidence of altered endothelial function in Type 1 diabetes, with a decreased production of deaggregatory substances e.g. prostacyclin [7] [8] [9] 13] , an increased formation of yon Willebrand factor [1, 10] and decreased release of plasminogen activator [14, 15] .
The relationship between the platelet and endothelial functional abnormalities in Type 1 diabetes is controversial. It has been debated, for instance, whether the platelet aberrations are secondary to the endothelial dysfunction or vice versa [1] and even if they are totally independent of each other.
As more marked platelet changes have been found in Type 1 diabetic patients with pronounced vascular disease, the disturbed platelet function might be a consequence of the vascular disorder rather than the reverse. The observed changes in carbohydrate, protein, metal ion and lipid metabolism [16] [17] [18] [19] [20] [21] [22] [23] in Type l diabetes have also been proposed as causes of the increased platelet aggregability, as have circulating immune complexes [24] , hormonal aberrations and changes in the activities of certain enzymes, e.g. phospholipase A2 [7] .
Children acquiring Type 1 diabetes as a rule have no vascular disease, and furthermore they lack factors that influence the platelet tests such as ageing, drug intake and smoking and therefore represent an ideal experimental group in this respect. In a cross-sectional study [25, 26] it was fbund that children with Type 1 diabetes of a 2-8 year duration exhibited both increased platelet aggregability in vitro and a reduced vasodilative capacity in vivo. To further elucidate the hypothesis of a disturbance of the platelet/blood vessel wall interaction in the pathogenesis of diabetic angiopathy, we designed a study in which a population-based cohort of newly diagnosed children with Type 1 diabetes were investigated prospectively for disorders of platelet or vascular function from the day of diagnosis before the very first insulin injection and then at 6, 12 and 24 months. The aim of this work was to investigate the platelet sensitivity to aggregating agents during the first two years of Type 1 diabetes and to try to relate any abnormalities to disturbances in carbohydrate, protein, metal ion and lipid metabolism.
Subjects and methods
All children (n = 36) in the county of Uppsala, Sweden, with Type 1 diabetes mellitus newly diagnosed between December 1982 and October 1984 were included prospectively in a study on early vascular and platelet dysfunction. Patients under 3 years of age were excluded from those parts of the study in which repeated venepuncture was necessary. Thirty children of ages 3-15 years (mean = 9.3), 19 girls and 11 boys, were available for the study of platelet aggregability. The patients were investigated on admission (n = 19) to hospital before the very first insulin injection, and followed up six months (n = 27), one year (n = 30) and two years (n = 28) after diagnosis. On all four occasions 18 children were investigated. Any samples showing coagulation or haemolysis during sampling, and samples from patients who had taken salicylates in the previous two weeks were discarded. This was the reason for the small number of children with diabetes investigated on admission. Forty-four healthy children (27 girls and 17 boys) aged 4-16 years (mean = 11.5) (20 relatives and neighbours of hospital staff and 24 peers of the children in the study group) served as control subjects. They were investigated once at the 24 month follow-up of their peers with Type I diabetes. Two control children were excluded on account of salicylate intake. After fasting all children visited the clinic voluntarily to offer a blood specimen. All blood samples were taken before insulin injection and breakfast at 07.00-08.00 hours, except those samples taken on admission for children with Type 1 diabetes. In those children, blood samples were taken immediately after the diagnosis of diabetes, before insulin was given. In all subjects, an antecubital vein was punctured with a 21 Gauge cannula, and 9 ml of free-flowing blood was collected without venous stasis into a plastic syringe containing 1 ml of 3.8% sodium citrate for platelet aggregation studies. The citrated blood was immediately prepared and platelet rich plasma (PRP) and platelet poor plasma (PPP) were obtained by centrifugation at 20~ at 150 x g for 15 rain and 1,500 x g for 10 min, respectively. The platelet count in PRP, which was not significantly different between the groups, was determined on a Thrombocounter C (Coulter Electronics, Hialeah, Fla, USA), and was adjusted to 300 x 109/1 by the addition of homologous PPP. The adjusted PRP was kept in plastic tubes covered with para film at room temperature and the aggregation studies were all started within 40 rain after sampling. insulbas. During the period of the study, a change was made to three insulin injections per day in five patients, and one patient received four injections per day after one year of treatment. The diabetic diet followed the current Swedish regimen, consisting in a regulated diet intended to supply 50-55% of the energy intake from carbohydrate, 30-35% from fat and 15-20% from proteins. The diet should be rich in polyunsaturated fatty acids and the carbohydrates should have a high fibre content. According to an earlier study our diabetic children adhere relatively well to this recommendation, except for fat intake which was slightly higher than that recommended [28] . Fasting plasma glucose and 24 h urine glucose excretion were determined by routine methods. immunoturbidimetric method, and the concentrations of calcium, magnesium and zinc in serum were measured by atomic absorption spectrometry [29] . Triglyceride (TG) and cholesterol concentrations were assayed in serum and in the isolated lipoprotein fractions by enzymatic methods, and the concentrations of serum apolipoproteins (apo) A-I, A-II and B were determined by turbidimetry [23] .
The study was approved by the Ethics Committee of the Medical Faculty, University of Uppsala, Uppsala, Sweden.
Statistical analysis
Wilcoxon's signed rank test was used to test differences between groups of subjects. Differences between repeated experiments in the 18 patients where complete longitudinal data were obtained were tested by paired Student's t-tests. Correlations within a group were analysed by Spearman's coefficient of correlation (rs). Correlations of p < 0.01 were considered as statistically significant.
Results

Platelet aggregability in Type I diabetic children compared with control children
Collagen. In the children with Type 1 diabetes, platelet aggregation (3 min) induced by low-dose collagen (0.5, 1.0 mg/1) was lower at the time of diagnosis than in healthy control children (p < 0.05; p < 0.01, respective- (Fig.2A) . The aggregation velocity induced by collagen (0.5, 1.0 mg/1) was significantly reduced on admission (both p < 0.001) and after 6 months (p < 0.001 and p < 0.01, respectively) in comparison with that in healthy control children. After 1 and 2 years of treatment, there was no significant difference from the control children. The aggregation velocity after the addition of collagen 5.5 mg/1 was significantly lower than that in the control children at onset of the disease (2 < 0.01), but not later (Fig.2 B) .
Adenosine diphosphate. The magnitude of the shape change induced by ADP (3.3 and 6.6 ~mol/1) was relatively small at diagnosis of Type I diabetes but was not significantly smaller than in the healthy control children (Fig. 3 A) . The primary wave aggregations induced by ADP (0.55, 1.1, 3.3 and 6.6 ~tmol/1) were slightly higher at diagnosis of Type i diabetes than in healthy control children, but this difference was only significant in the test with ADP 1.1 p~mol/1 (Fig. 3 B) . The platelet aggregation (3 min) induced by ADP did not change significantly from that in healthy control children (Fig. 3 C) .
Arachidonic acid. On admission, the platelets of the children with Type 1 diabetes showed an increased response to AA at the lower concentration (0.25 mmol/1) compared with the platelets of control children (3 min aggregation p < 0.01 ; aggregation velocity p < 0.05). At the higher concentration (1.0 mmol/1) there was no such difference (Fig.4A, B) .
Longitudinal changes in platelet aggregability in Type 1 diabetes
Collagen. The aggregations and aggregation velocities induced by low doses of collagen (0.5, 1.0 mg/1) increased significantly from time of admission to 24 months ( Fig.2A, B ) (all p < 0.001). The aggregation velocity after stimulation by a high dose of collagen (5.5 mg/1) also increased slightly (p < 0.05), but the aggregation (3 min) was unchanged ( Fig. 2A) .
Adenosine diphosphate. The magnitude of the platelet shape change induced by ADP (3.3 and 6.6 ~mol/1) was larger after 6 and 12 months of Type 1 diabetes mellitus (all p < 0.01) than at diagnosis (Fig.3A) . The primary wave induced by ADP was high on admission and after 6 months, but decreased gradually from 6 to 24 months (Fig. 3 B) . The platelet aggregation (3 min) induced by ADP did not change significantly during the observation period (Fig. 3 C) .
Arachidonic acid. The maximal aggregation and aggregation velocity induced by a low dose of AA (0.25 mmol/l) decreased from admission to follow-up 2 years after diagnosis (p < 0.05), while the aggregation induced by the higher dose AA (1.0 mmol/1) did not change significantly (Fig.4A, B) .
Platelet aggregability -its relationship to sex and age
The platelet aggregability did not differ significantly between males and females with diabetes either on admission or later, or between male and female control children, after stimulation by collagen, ADP or AA.
There was no significant difference between Type 1 diabetic or control children below the age of 10 years and those above this age. 
Platelet aggregability -its relationship to diabetes treatment and control
The carbohydrate indices improved significantly during the first months of treatment and deteriorated slightly after 6 months (Table1). On admission, ADP (3.3 ~tmol/1)-stimulated primary wave aggregation and aggregation after 3 min correlated to 24 h urine glucose excretion (r = 0.67, p < 0.01 ; r = 0.62, p < 0.01, respectively (Fig.5A) . After 6 months, the magnitude of platelet shape change induced by ADP at 6.6~tmol/1 correlated negatively to urine glucose excretion (r = 0.50, p < 0.01) and tended to correlate (negatively) to HbA~c (p < 0.05). With these exceptions, the platelet aggregation induced by ADP, collagen and AA in all doses was not significantly correlated to any parameters of carbohydrate control measured on any occasion or to insulin dosage per kg body weight. In the control group no significant correlation was found between platelet aggregability and any lipoprotein lipid variable.
ADP-stimulated aggregation correlated positively to several lipoprotein fractions, especially TG-containing lipoproteins, on the day of admission (Fig. 5 B and C, Table 2 ). After one year serum orosomucoid was negatively correlated to the ADP-induced primary wave and 3 rain aggregation (r= -0.59; p <0.001 both); the latter variable was negatively correlated to apo A-I (r= -0.55; p < 0.0t) after 2 years.
Discussion
To our knowledge this is the first study on in vitro platelet aggregability in children with newly diagnosed Type1 diabetes. Furthermore, no population-based prospective study has been undertaken in which the changes in platelet sensitivity to aggregating agents over time have been evaluated with concomitant investiga-tions of vascular dysfunction and metabolic changes in Type 1 diabetes. We made a new and unexpected finding of a decreased sensitivity to collagen-induced aggregation on admission, before the very first insulin injection. The aggregating capacity improved slowly and at a diabetes duration of one year the sensitivity to collagen was normalised. This should be compared with the findings in cross-sectional studies on adult populations with long-standing Type 1 diabetes [4-6, 9, 30] , and also in our earlier study in children with an Type 1 diabetes duration of 2-8 years [25] of enhanced aggregability to low-dose collagen only. In a preliminary analysis of the first patients we suggested a normal collagen aggregation on admission and hyperaggregability after 12 months [31] . The discrepancy with our present results is explained by a lower response to collagen in the control children used in the preliminary study. In that study historical, non-fasting control children were used, whereas in this study matched fasting peers were investigated in parallel at the time of 24 month follow up.
No correlation to measured changes in carbohydrate, protein, metal or lipid metabolism could explain the decreased collagen-induced aggregability on admission. It has been proposed that zinc augments collagen aggregation [32] . Serum zinc was low in the children with diabetes on admission. It could be speculated that the reduced response was related to the reduction in serum zinc. However, these two variables were not statistically correlated. Furthermore, zinc also augments ADP-induced aggregation [32] , which was not reduced in the present study. Perhaps, the circulating levels of catecholamines are increased in the untreated newly diagnosed children and a consequent down-regulation of alpha-adrenergic binding sites on the platelet membrane results in a decreased aggregability in response to collagen [33, 34] . An alternative hypothesis is a disturbance of collagen adhesion to the outer surface of the platelet membrane and/or a defect in signal transmission and in activation of phospholipases (A2 or C), resulting in reduced metabolism of AA to thromboxane A2 [35] . This possibility is supported by the finding of normal high-dose collagen-induced aggregation (3 min) which is independent of the AA pathway [36] . A decreased aggregability on admission could be an advantage, since dehydration and catecholamine release might increase the risk of acute rheological disturbances and acute thrombus formation in the circulation.
Another finding in this study was the increased platelet aggregability in response to low-dose ADP and AA. This platelet aberration in the newly diagnosed children with Type 1 diabetes was small, however, and was not significantly different from that in control children at 6, 12 or 24 months. It corresponds quite well with the finding in adults with long standing Type 1 diabetes and vascular complications [4-71 and also with our observations in children with diabetes of 2-8 years duration [25] . The present study also demonstrates that platelet hyperreactivity can be normalised, at least in the first year of the disease.
ADP-induced aggregation on admission was highly statistically correlated to the increase in lipoprotein lipid fractions, which is part of the deterioration of carbohydrate and lipid metabolism in the insulin-deficient newly diagnosed diabetic patients. This correlation was also found for urinary glucose excretion during the first 24 h, which is also a measure of the ongoing catabolism. The strong correlations between ADP aggregability and changes in lipoprotein lipid fractions and carbohydrate metabolism indicate that the metabolic derangement due to insulin deficiency occurs in parallel with platelet dysfunction [23] , but Changes in the lipid composition might also have a direct effect on the platelet membrane. Hyperlipoproteinaemia and incorporation of high concentrations of cholesterol in platelet membranes increases platelet aggregability [16, 17, 37] . The fatty acid composition of platelet membrane phospholipids, dietary enrichment with unsaturated fats and the serum lipid composition have all been shown to be of importance for platelet function [18;-21, 25, 38, 39] . Optimal treatment of Type 1 diabetes includes normalisation of carbohydrate and lipid metabolism, which also favourably reduces the hyperreactivity of platelets.
The difference in platelet aggregation between Type I diabetic and control children could not be explained by any difference between sex or age groups, but was a generalised finding. With the exception of the strong correlation between the hyperlipoproteinaemia on admission and the increased ADP sensitivity at that time, no obvious single biochemical changes can explain the resuks found in this study. Even if the most speculative finding was the alteration of platelet aggregability on admission, the most important practical conclusion is probably that conventional insulin treatment is satisfactory from the point of view of normalisation of platelet sensitivity during the first two years. As we found in another part of this prospective study [40] that some aspects of vascular function deteriorated after two years in the same group of patients with now seemingly completely normal platelet aggregability, the early decrease in vascular reactivity could not have been due to primary changes in the platelets, at least not to changes influencing the tendency to aggregate.
The findings in the present study support the hypothesis that changes in platelet aggregability are secondary or late events and do not explain the early vascular dysfunction in vivo. Platelet hyperreactivity may play a role later as part of a vicious circle in the development of diabetic angiopathy, where an increased serum concentration of von Willebrand factor, a decreased capacity for prostacyclin formation in the endothelial cells and disturbed plasminogen activation and fibrinolysis promote platelet adherence and aggregation, vasoconstriction, and release of platelet derived growth stimulating factors. This indicates that platelet abnormalities together with a disturbance of lipid metabolism may be relevant for the progression of the macroangiopathy rather than for the microangiopathy of diabetes mellitus.
